Lundbeck to acquire Longboard Pharmaceuticals for $2.6 billion
On Oct. 14, 2024, Lundbeck and Longboard Pharmaceuticals announced an agreement for Lundbeck to acquire Longboard for payment…
Biotechnology | Disease | Genomics | Life Science News | Neurology | Non-Profit Research | Therapeutics
University of Copenhagen researchers discovered longevity gene
On Sep. 4, 2024, researchers at the University of Copenhagen announced the discovery of a gene that has…
FDA approved first drug to treat agitation symptoms associated with dementia due to Alzheimer’s disease
On May 11, 2023, the U.S. Food and Drug Administration (FDA) announced the supplemental approval of Otsuka Pharmaceutical…
FDA approved Lundbeck’s VYEPTI™ – the first and only intravenous preventive treatment for migraine
On Feb. 21, 2020, Lundbeck announced that VYEPTI™ (eptinezumab-jjmr) had been approved by the U.S. Food and Drug…
Lundbeck acquired Alder BioPharmaceuticals for $1.95 billion
On Oct. 22, 2019, Lundbeck, located in Valby, Denmark, announced it had completed its acquisition of Bothell, Washington-based…
ZymoGenetics was instrumental in development of new hemophilia drug
On Mar. 27, 1999, Novo Nordisk, the ZymoGenetics parent company, announced approval of NovoSeven by the Food and…
The Lundbeck Company was founded
On Aug. 14, 1915, Hans Lundbeck founded a company in Copenhagen, Denmark, which dealt in everything from machinery…